Cytokinetics inc
WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%.
Cytokinetics inc
Did you know?
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people … WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …
WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with ... WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential …
WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) . Shares of the … WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people ...
WebAbout The Company. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing potential treatments for debilitating diseases in which muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug ...
WebFollowing an internship in clinical operations at Cytokinetics Inc. , I've realized my passion for developing and overseeing clinical trials of every … dhl51trackingWeb1 day ago · Company Profile CYTK. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced … cigna stress wavesWebCytokinetics. Pharmaceuticals · California, United States · 253 Employees . Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. cigna state of ct dentalWebDec 13, 2024 · Dec 13 (Reuters) - The U.S. Food and Drug Administration's panel of outside experts did not lend its support to Cytokinetics Inc's (CYTK.O) heart drug, citing insufficient data on safety and ... dhl522 iccas.ac.cnCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. cigna sterling lifeWebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% … dhl 6710 oakley industrial blvd union city gaWebHeadquarters United States of America. Address ., 280 East Grand Avenue, South San Francisco, California, 94080. Website cytokinetics.com. Telephone 1 650 6243000. No of Employees 253. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX. dhl 59 craywick